Xu and Chen et al. observed that p53/miR-503-5p/PUMA signaling axis regulates chemotherapy response in colorectal carcinoma, and suggest that miR-503-5p plays an important role in the development of multidrug-resistance by modulating PUMA expression41. This evidence concerns the gene BBC3 and colorectal carcinoma.